Welcome Guest
Sign In
Register
Products
Popular Categories
Antibody Search
ELISA Kit Search
Biomolecules
Flow Cytometers
Thermal Cyclers
Microscopes
Transfection Reagents
Featured Products
New Products
Applications
ELISA
Western Blot
3D Cell Culture
PCR
Quantitative PCR
Digital PCR
Cell and Gene Therapy
In Vivo Models
Resources
eBooks
Bench Tips
Tech Insights
Editorial Articles
News
Product Reviews
Future Lab
Application Notes
Infographics
Events
Promotions
Multimedia
Biocompare Webinars
Technologies Transforming Precision Medicine
Immunotherapy
Reproducibility
Transformative Technologies
Podcasts
Bench Tip Videos
All Videos and Webinars
Life Science Webinars
Write a Review
Antibodies
Kits/Reagents
Equipment
Services
White Paper
Register
Sign In
Biocompare
Products
RNAi Technology
RNAi
DCAMKL1 siRNA (h)
Supplier Images
Published Figures
DCAMKL1 siRNA (h)
DCAMKL1 siRNA (h) from Santa Cruz Biotechnology, Inc.
Be the first to write a review!
Citations:
(6)
Figures:
(7)
Supplier Page
Supplier Page from
Santa Cruz Biotechnology, Inc. for
DCAMKL1 siRNA (h)
Description
DCAMKL1 siRNA (h)
Product Specs
Company Info
Citations
Reviews
Product Specs
Item
DCAMKL1 siRNA (h)
Company
Santa Cruz Biotechnology, Inc.
Price
$293.00
Supplier Page
View Company Product Page
Catalog Number
sc-45618
Gene Name
doublecortin-like kinase 1
Quantity
10 µM
Type
siRNA/dsRNA
NCBI Gene Aliases
CL1, CLICK1, DCAMKL1, DCDC3A, DCLK
NCBI Full Gene Name
doublecortin like kinase 1
Species
human
Add to Compare List
Santa Cruz Biotechnology, Inc.
10410 Finnell Street
Dallas
,
Texas
75220
United States
Phone
: 1-800-457-3801
831-457-3801
Company Profile
Website:
http://www.scbt.com/
Citations (6)
(1)
DCLK1 Regulates Tumor Stemness and Cisplatin Resistance in Non-small Cell Lung Cancer via ABCD-Member-4
Molecular therapy oncolytics
September 25, 2020
Panneerselvam J, Mohandoss P, Patel R, Gillan H, Li M, Kumar K, Nguyen D, Weygant N, Qu D, Pitts K,
et al
.
(2)
DCLK1-Isoform2 Alternative Splice Variant Promotes Pancreatic Tumor Immunosuppressive M2-Macrophage Polarization
Molecular cancer therapeutics
July 1, 2020
Chandrakesan P, Panneerselvam J, May R, Weygant N, Qu D, Berry WR, Pitts K, Stanger BZ, Rao CV, Bronze MS,
et al
.
(3)
Alternative splice variants of DCLK1 mark cancer stem cells, promote self-renewal and drug-resistance, and can be targeted to inhibit tumorigenesis in kidney cancer
International journal of cancer
September 1, 2018
Ge Y, Weygant N, Qu D, May R, Berry WL, Yao J, Chandrakesan P, Zheng W, Zhao L, Zhao KL,
et al
.
(4)
Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells
Molecular cancer
February 1, 2017
Chandrakesan P, Yao J, Qu D, May R, Weygant N, Ge Y, Ali N, Sureban SM, Gude M, Vega K,
et al
.
not matching any of the
mouse
genes were obtained (
Ambion
Inc., Austin, TX, USA).
DCLK
siRNA (h) (#
SC45618
), RELA siRNA (h) (#
SC29410
) and NOTCH1 siRNA (h) (#
SC36095
) were obtained from
Santa Cruz Biotechnology
(5)
Survival of Patients with Gastrointestinal Cancers Can Be Predicted by a Surrogate microRNA Signature for Cancer Stem-like Cells Marked by DCLK1 Kinase
Cancer research
July 15, 2016
Weygant N, Ge Y, Qu D, Kaddis JS, Berry WL, May R, Chandrakesan P, Bannerman-Menson E, Vega KJ, Tomasek JJ,
et al
.
(6)
miR-613 inhibits the growth and invasiveness of human hepatocellular carcinoma via targeting DCLK1
Biochemical and biophysical research communications
May 13, 2016
Wang W, Zhang H, Wang L, Zhang S, Tang M.
<<
<
>
>>
Reviews
Be the First to Write a Review!
DCAMKL1 siRNA (h) from Santa Cruz Biotechnology, Inc.
Supplier Page
View Company Product Page
$293.00
Product Specs
Company Info
Citations
Reviews
Back To Top